A case of giant cell tumor of soft parts in a horse.

The research article describes a case where a 12-year-old horse was diagnosed and treated for a rare skin tumor, known as a giant cell tumor of soft parts (GCTSP), and shows no signs of recurrence 8 months post-surgery.

Background

• The paper reports on an unusual case where a 12-year-old British Warmblood mare was examined due to a skin lesion on her back. The initial assessment, made through a cytologic examination of fine-needle aspirates from the distinguishing mass, indicated that the horse may have a giant cell tumor of soft parts (GCTSP).
• Notably, GCTSP are generally rare skin tumors. They have been detected in various domestic species, including horses. When appearing in horses, these tumors typically present as superficial skin lesions without aggressive biological behavior, further complicating their classification and treatment.

Treatment and Diagnosis Confirmation

• The mare underwent laser surgical excision to remove the tumor. Postoperative treatment included methyl aminolevulinate (MAL) photodynamic therapy (PDT), a type of therapy that uses light to kill cancer cells.
• A further histologic examination of the mass confirmed the earlier cytologic diagnosis. Histologic examination involves studying the microscopic structure of tissue and is more definitive in establishing a diagnosis.

Classification of GCTSP

• GCTSP were previously classified as a giant cell variant of malignant fibrous histiocytoma, an aggressive and typically high-grade type of tumor.
• However, due to their superficial nature and less aggressive behavior, they have now been categorized as GCTSP, or giant cell tumors of low malignant potential, within the broader category of fibrohistiocytic neoplasms (a group of tumors formed from histiocyte cells).

Post-Treatment Follow-up

• Eight months after the surgery and photodynamic therapy, there was no evidence of the tumor recurring. This indicates that the treatment was successful, at least in the short-term.